Quantcast

Health Care Sector Update for 07/17/2017: RDHL


Shutterstock photo

Top Health-care stocks:

JNJ: +0.3%

PFE: -0.1%

ABT: +1.3%

MRK: flat

AMGN: -0.1%

Health-care shares were mixed in pre-market trade Monday.

In health-care stocks news, Redhill Biopharma ( RDHL ) reported that the last patient enrolled in the phase II study with Bekinda 12 mg for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) has completed the treatment course and follow-up visit. Top-line results are expected in September, the company said.

Shares in the company were 1.9% lower at $8.64 in pre-market trade. The stock has traded between $8.16 and $16.54 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.



This article appears in: Investing , US Markets
Referenced Symbols: RDHL


More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities








Research Brokers before you trade

Want to trade FX?





Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com